Lantern Pharma is trading 5.51% down at $0.73, with no new company-specific announcement explaining the October 29 move identified in recent press-release listings. - The latest listed releases were dated October 8 and October 7. - Broader markets were lower: the Nasdaq fell 1.64%, the S&P 500 0.53%, and the Dow 0.51%. Weakness may have contributed, but no direct cause is established. - Lantern Pharma had earlier been reported up 7.3% that morning, marking a sharp reversal during the session.